In December 2022, Blume’s former fund, Fund IV, ended with more than $250 million. Fund V will keep supporting Indian entrepreneurs in the health-tech, consumer, fintech, and deeptech sectors while adhering to its early-stage investing strategy. Initial investments in businesses like Mave Health, Confido, Lucira, Ozi, PowerUp Money, and iDO have already been made by the fund.
With large dividends to Limited Partners from early fund vintages, the company reported higher departure activity in 2025. This year, Blume anticipates exceeding an overall DPI of $80 million across all of its funds. As the first portfolio firm to submit its draft prospectus to regulators, Turtlemint’s IPO pipeline is also gaining momentum.
Blume Ventures supports technology-driven entrepreneurs aiming for global expansion and Indian markets by investing mostly in seed and pre-Series A rounds. Mobility, consumer technology, space, and financial services are all included in the company’s portfolio.